Biogen’s Hemophilia B drug Gets Green Signal in Canada

Biogen’s Hemophilia B drug Gets Green Signal in Canada

The latest statement by the Biogen Idec Inc. has revealed that the long-lasting hemophilia B drug, Alprolix, has gained green signal from Canada. The company stock closed at $347.04 in the US stock market on Thursday.

The main advantage of the drug is that it is administered only once a week or once in every 10 to 14 days to protect against bleeding episodes whereas earlier treatments have to be administered two or three times a week.

The officials reported that the single injection of the drug is capable of controlling 90% of bleeding in late-stage clinical trial.

Hemophilia B is a rare inherited disorder which affects about 4,000 people in United States and about 25,000 across the world. Hemophilia A is another more common form of the disease that affects about 20,000 people in the US. Biogen and Swedish Orphan Biovitrum AB are developing the Alprolix which is expected to be approved in US in later half of the year.

Biogen is working on another mission to develop a drug, Elocate, to treat hemophilia A, disease in which patients suffer reduced levels of coagulation factor VIII. The company said that the treatments for hemophilia B generate about $1 billion per year whereas the market for hemophilia A therapies generates revenue of about $6 billion.

The Cambridge based company added that the approval of the Alprolix will generate sales of $286 million by 2019 while Elocate can generate sales over $1.1 billion.


FrenchTribune Specials

Tech giants set to open up an overwhelming VR world by year-end

The overwhelming world of 'Virtual Reality' (VR) is being opened up by Facebook and Valve in the near future. The innovative plans of the two tech giants will apparently unfold an all-new virtual world for consumers by the end of this year.

'Virtual Reality' was popularized in 1980s by Jaron Lanier, who started a company called VPL...

Most Popular

US Census Bureau releases new estimates about NYC population

The latest estimates released by the US Census Bureau...

Space X Dragon capsule departs from ISS to return to earth

A Space X Dragon capsule has departed from the...

NASA advancing with its initiative to explore solar system using small satellite

As part of its ongoing efforts to explore the solar...

Scientists discover new method to help in treatment of rheumatoid arthritis

A new method has been discovered by scientists to help...

Poll

Can Greece Come out of Economic Problems: